Ultrasound-Guided Core Needle Biopsy to Stage Urothelial Carcinoma of the Bladder (US UCB)

Ultrasound-Guided Core Needle Biopsy to Stage Urothelial Carcinoma of the Bladder

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT07029256

Enrollment

100

Registered

2025-06-19

Start date

2024-07-26

Completion date

2030-07-30

Last updated

2026-06-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bladder Urothelial Carcinoma

Brief summary

This study is being done to test the feasibility and accuracy of using an ultrasound-guided core needle biopsy technique as a potential tool for staging urothelial carcinoma of the bladder (UCB).

Interventions

OTHERNon-Interventional Study

Non-interventional study

Study design

Observational model

COHORT

Time perspective

CROSS_SECTIONAL

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Undergoing radical cystectomy for confirmed or suspected urothelial carcinoma of the bladder * Prior abdominal imaging

Exclusion criteria

* History of partial cystectomy or complex bladder reconstruction or substitution (i.e. bladder augment or urothelial recurrence in a neobladder)

Design outcomes

Primary

Measure	Time frame	Description
Concordance between US and core needle biopsy stage and final surgical specimen pathologic stage	Baseline (after completion of bladder surgery)	The radiology-assessed tumor stage from the ultrasound (US) and the core needle biopsy-assessed tumor stage will be compared with the final pathologic tumor stage.

Countries

United States

Contacts

CONTACTHosanna Yeadon, BA

biffert.hosanna@mayo.edu507-538-5019

CONTACTClinical Trials Referral Office

mayocliniccancerstudies@mayo.edu855-776-0015

PRINCIPAL_INVESTIGATORVidit Sharma, MD

Mayo Clinic in Rochester

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 11, 2026